Cryoport unveils state-of-the-art cryogenic shipping system for transporting lifesaving biologics and temperature-sensitive therapies

New high-volume shipping system, improving patient accessibility, will be showcased by cryoport systems at phacilitate's advanced therapies week in dallas nashville, tenn. , jan. 21, 2025 /prnewswire/ -- cryoport, inc. (nasdaq: cyrx) ("cryoport" or "the company"), a global leader in supply chain solutions for the life sciences, today unveiled its cryoport express® cryogenic hv3 shipping system ("hv3"), the company's newest product innovation in cryoport's comprehensive portfolio of global end-to-end temperature-controlled supply chain offerings.
CYRX Ratings Summary
CYRX Quant Ranking